Note 15 - Segment and Geographic Information (Details) - Sales by Product Group (USD $) In Thousands, unless otherwise specified	3 Months Ended	6 Months Ended
Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012
Net sales by product group:
Net sales by product group	$ 100,203	$ 82,056	$ 196,247	$ 167,210
Transfusion [Member]
Net sales by product group:
Net sales by product group	85,559	80,362	168,549	163,931
Transplant & Molecular [Member]
Net sales by product group:
Net sales by product group	$ 14,644	$ 1,694	$ 27,698	$ 3,279

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

Name:	us-gaap_SalesRevenueNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration